Powered by
-
PFE Stock Chart
Historical PFE Prices
Pfizer Stock Analysis
Rating: Sell
Total Grade: D
Analysis Breakdown
| PFE Stock Grade: | D |
| Fundamental Grade: | C |
| Quantitative Grade: | D |
| PFE Earnings | |
| Earnings Growth: | C |
| Earnings Momentum: | D |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | C |
| PFE Financial Information | |
| Sales Growth: | D |
| Operating Margin Growth: | C |
| Cash Flow: | C |
| Return on Equity: | A |
Pfizer Stock: Weekly View
| This Week: | D |
|---|---|
| Last Week: | D |
| Two Weeks Ago: | C |
PFE Stock predictions, Articles, and Pfizer News
- From InvestorPlace
- From the Web
-
FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs - May 18, 2018
The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are. Continue…
-
Investors Need to Adopt a Different Mindset for Big Pharma and Biotech Stocks - May 17, 2018
Both biotech stocks and big pharma stocks involve a different mindset. Treat biotech stocks like options and big pharma stocks like ETFs. Continue…
-
9 Great Income Investments You’ve Never Heard Of - May 8, 2018
They may be small and/or obscure, but these picks are among the best income-producing assets you can easily own today. Continue…
-
Pfizer Inc. Is Stuck in a Trading Range – for Now - May 3, 2018
PFE's latest quarterly earnings report neither inspired nor scared investors away. Pfizer stock is an income play for now. But PFE stock's value will grow as sales of the 25 to 30 new drugs it has in the approval pipeline ramp up in the years ahead. Continue…
-
Stagnant Revenues Continue to Hamper the Growth of Pfizer Inc. - May 2, 2018
PFE stock fell as the company reported better-than-expected earnings, but stagnant revenue continues to hurt Pfizer stock. Continue…
-
Pfizer Inc. Stock Down on Q1 Revenue Miss - May 1, 2018
Pfizer (PFE) stock was down on Tuesday following the release of the company's earnings report for the first quarter of the year. Continue…
-
Pfizer Inc. Stock Is Boring But Great for Your Portfolio’s Health - May 1, 2018
Fundamentally PFE is too cheap. So go long on this earnings dip inside a nervous market. Management is proven for decades and is bankable for the future. Continue…
-
5 Top Stock Trades for Tuesday Morning - May 1, 2018
On Tuesday, there are a number of top stock trades to keep on our radar. A few of them include Square, Twitter and First Solar. Continue…
-
10 Risky (But Rewarding) Small-Cap Stocks to Buy Now - April 27, 2018
These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward. Continue…
-
5 Drug Stocks Poised to Surpass on Earnings This Quarter - April 17, 2018
The outlook for the upcoming first-quarter results looks bright. Compare Brokers.... Continue…
